60 Degrees Pharmaceuticals SXTP Q3 2025 earnings
Reported November 13, 2025 · Before market open
Revenue$437.6KBeat by $237.6K
EPS-$2.64Miss by $0.80
Revenue estimate$200.0K
EPS estimate-$1.84
Next report
Aug 12, 2026 (In 2 weeks)Revenue estimate$185.0K
EPS estimate-$0.74
Versus estimates
Revenue
Diluted EPS
Ask the moment 60 Degrees Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did 60 Degrees Pharmaceuticals report Q3 2025 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were 60 Degrees Pharmaceuticals's Q3 2025 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $437.6K and eps of $-2.64 for Q3 2025.
- Did 60 Degrees Pharmaceuticals beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $200.0K by $237.6K. EPS missed the consensus estimate of $-1.84 by $0.80.
- How did 60 Degrees Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 223.4% from $135.3K a year earlier and eps grew 43.2% from $-4.65.
- Where can I find 60 Degrees Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001554855-25-002032) directly on SEC EDGAR. The filing index links above go to sec.gov.